South Korea’s healthcare challenge is no longer just about how much people spend over a lifetime, but when those costs arrive – increasingly clustered in the final years of life, when care is most intensive and expensive.
A new analysis by the National Health Insurance Service shows that lifetime medical spending now averages KRW246.6 million (about $190,000) per person, but the more profound shift lies in the delayed peak of healthcare use.
Where medical costs once peaked in the early 70s, they now crest close to age 80, reflecting a society that survives longer but depends more heavily on medical intervention at the end.
Living longer, leaning more on medicine
In 2004, annual medical spending was highest at age 71, averaging KRW1.72 million (about $1,320).
By 2023, that peak had moved to age 78, with yearly costs rising to about KRW4.46 million (around $3,430) – a dramatic increase signalling longer periods of late-life treatment rather than healthier ageing.
The data suggests that longevity gains are being accompanied by extended medical dependency.
A report from The Korea Bizwire cited that advances in treatment and diagnostics have prolonged life, but often with chronic conditions that require continuous medication, hospital visits and long-term monitoring.
The burden is also unevenly distributed as women incur significantly higher lifetime medical costs than men – not because they are sicker, but because they live longer.
On average, women spend about KRW214.7 million (roughly $165,000) over their lives, compared with KRW182.6 million (about $140,000) for men, extending the period during which healthcare services are used.
YOU MAY ALSO LIKE: Dry January: What it is and why it matters
The hidden cost of routine care
Contrary to common assumptions, the largest share of lifetime medical costs does not come from major surgeries or hospital stays.
Instead, pharmacies and local clinics quietly accumulate the highest spending over time, underscoring how routine care becomes a dominant driver of national healthcare costs in an ageing society.
Serious disease can quickly shift lifetime spending trajectories.
A cancer diagnosis at age 30, for instance, adds more than KRW111 million (about $85,000) in expected lifetime medical costs, with pancreatic, lung and breast cancers among the most expensive to treat.
For policymakers, the implications are growing more urgent.
In 2004, each additional year of life expectancy increased lifetime medical spending by about 20 per cent.
Today, that same gain raises costs by more than 50 per cent, as advanced treatments and prolonged care become the norm in old age.
Researchers say the trend points to a clear policy challenge: without extending healthy life expectancy – years lived without serious illness – the financial weight of healthcare will continue to shift toward the end of life, placing mounting pressure on South Korea’s insurance system and public finances.
READ NEXT: Restrictions on junk food advertising come into force in the UK
Adam Peaker 
Newsjustnews writers 
Carmela Calling